Chen, J., Yao, Q., Li, D., Zhang, J., Wang, T., Yu, M., . . . Wang, L. (2013). Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: Efficacy and safety in a prospective, randomized, phase II study. BioMed Central.
Citação norma ChicagoChen, Jianghao, et al. Neoadjuvant Rh-endostatin, Docetaxel and Epirubicin for Breast Cancer: Efficacy and Safety in a Prospective, Randomized, Phase II Study. BioMed Central, 2013.
MLA引文Chen, Jianghao, et al. Neoadjuvant Rh-endostatin, Docetaxel and Epirubicin for Breast Cancer: Efficacy and Safety in a Prospective, Randomized, Phase II Study. BioMed Central, 2013.
警告：這些引文格式不一定是100％准確.